Bayer

Germany

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
9 approved
1 in Phase 3
Next date
BAY3389934, Phase 1 trial completes
Drugs
23
in active trials · 104 in all
Trials
33 active
308 since 2021

Drugs23

DrugHow it worksPartnerStageNext dateDetails
—
Approved 22 Jan 2027Phase 1 trial completes
Mineralocorticoid receptor antagonist
Approved 10 Apr 2027Phase 3 trial completes
—
Approved 30 Jul 2027Phase 3 trial completes
Transthyretin stabilizer
Approved in the EU 17 Sep 2027Phase 4 trial completes
HER2/EGFR inhibitor
Approved 28 Oct 2027Phase 3 trial completes
Kinase inhibitor
Approved 27 Apr 2028Phase 2 trial completes
Kinase inhibitor
Approved —
—
Approved —
Soluble guanylate cyclase stimulator
Approved —
—
Phase 3 —
—
Phase 2 29 Nov 2027Phase 2 trial completes
—
Phase 2 15 Jun 2029Phase 2 trial completes
—
Phase 1/2 18 Jun 2029Phase 1/2 trial completes
—
Phase 2 16 May 2030Phase 2 trial completes
—
Phase 1 25 Dec 2026Phase 1 trial completes
—
Phase 1 30 Apr 2027Phase 1 trial completes
Guanylate cyclase activators and stimulator
Phase 1 7 May 2027Phase 1 trial completes
—
Phase 1 8 Jun 2027Phase 1 trial completes
—
Phase 1 30 Nov 2027Phase 1 trial completes
—
Phase 1 26 Nov 2028Phase 1 trial completes

See all 23 drugs

Sign in free to see the whole list. No card, no password.

Sign in free

About

No active trial
81 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev

Follow Bayer

Following is part of Solo: you see every change to Bayer the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in